360° Coverage : Glaxo Effort To Verify Gene Data Represents Step For Open Science

2 Updates

Glaxo Effort To Verify Gene Data Represents Step For Open Science

Mar 27 2014, 6:11am CDT | by

GlaxoSmithKline’s efforts to fund a 50-person effort with two top universities to verify that the proteins it is picking as targets for drugs are actually involved in the diseases the company hopes...

Filed under: news

 
 
 

22 weeks ago

Glaxo Effort To Verify Gene Data Represents Step For Open Science

Mar 27 2014, 6:11am CDT | by

GlaxoSmithKline’s efforts to fund a 50-person effort with two top universities to verify that the proteins it is picking as targets for drugs are actually involved in the diseases the company hopes to treat are a big example of the Big Pharma dropping its veil of research secrecy.

The new Centre for Therapeutic Target Validation is a collaboration between the London-based drug giant, the Wellcome Trust Sanger Institute, which is one of the top genetics research hotspots in the world, and the European Bioinformatics Institute. The effort will take a “Big Data” approach to pooling genetic data and other information to pick drug targets.

“[Glaxo are] providing people and expertise based analysts with this incredible wealth of expertise,” says Ewan Birney, who will be the interim head of the center. “They’ve been doing this for a long time and the’ve had successes and they’ve had failures and, in some sense, they’ll be bringing those into the public domain. I’ve been surprised at how engaged GSK has been scientifically and how interesting this problem is to handle.”

Almost all medicines work by blocking or otherwise affecting specific proteins. For instance, statin drugs like Lipitor block an enzyme in the liver that helps the body create cholesterol; aspirin blocks enzymes involved in causing inflammation and clotting blood.

But one big problem for drug researchers is that they often aren’t sure they understand what the proteins they are targeting with experimental medicines do. Problems in the quality of public research, which can be wrong, can make this worse. This project hopes that big data — looking at information and especially human genetics — can make the odds of success for new medicines better.

Patrick Vallance, who heads basic research at GSK, says that in the past ten years genetics has gone from being “quite misleading” to “high throughput” and “reliable.”

“Every week there are something like three new rare genetic mutations causing a very rare disease are being identified,” says Vallance. “Every week there is new data coming up on common disease genetic variations. What that does is it creates massive information that is truly about human biology. All of a sudden you get a window into things that are genuinely causal across a range of diseases.”

Of course, fifteen years ago drug company research executives, including those at Glaxo, made similar claims about the sequencing of the human genome and the data produced by a slew of hot gene data companies. That led to a great many failures, some of which took years to read out. For Glaxo, the reminders of its deals with Human Genome Sciences are recent: the lupus drug Benlysta, which worked but has not generated much in the way of sales, and darapladib, a much hyped heart drug that recently failed in a big trial and that also, it turned out, had the unfortunate side effect of making patients smell bad.

But Vallance provides a strong argument that things are different this time. Creating drugs has always been about finding the right proteins to target, he says. Now genetics has become the best way to do that.

Birney insists that genetics provides something that other methods of biology don’t. When you look at a person’s genes, they’ll be for the most part the same throughout life. So when a gene is linked to a disease, it gives a real clue as to how the biology of a disease works. That’s how rare mutations that cause super-high cholesterol led to the cholesterol-lowering statins, and that’s how Birney and Vallance hope that this effort will lead to new drugs.

It used to be that drug companies tried to keep much of their biology research in-house and secret, so that they would start synthesizing promising new compounds before competitors. But this effort puts a lot more of Glaxo’s research out in the open. The bet is that the advantages of having lots of minds working on the problems of drug discovery will outweigh any advantages that secrecy would have provided.

Source: Forbes Business

 
Update
2

4 days ago

Khazanah throws MAS RM6b lifeline

Aug 29 2014 5:01pm CDT | Source: Business Times Singapore

August 30, 2014 1:15 AMKHAZANAH Nasional will inject RM6 billion (SS$2.4 billion) over three years to resuscitate loss-making Malaysia Airlines (MAS) under a recovery plan that includes even an Act of Parliament. Other key moves are migrating its operations, assets and liabilities to a new company (NewCo) ...
Source: Business Times Singapore   Full article at: Business Times Singapore
 

 
Update
1

5 days ago

MAS posts loss of RM307m for Q2

Aug 28 2014 5:00pm CDT | Source: Business Times Singapore

August 29, 2014 1:13 AMMALAYSIA Airlines (MAS) registered a loss of RM307 million (S$122 million) for the second quarter to end-June, but warned of worse to come in the second half when the "full financial impact of the double tragedies of MH370 and MH17 ...
Source: Business Times Singapore   Full article at: Business Times Singapore
 

 

Don't miss ...

 

<a href="/latest_stories/all/all/30" rel="author">Forbes</a>
Forbes is among the most trusted resources for the world's business and investment leaders, providing them the uncompromising commentary, concise analysis, relevant tools and real-time reporting they need to succeed at work, profit from investing and have fun with the rewards of winning.

 

blog comments powered by Disqus

Latest stories

US CDC calls for global response against Ebola
Washington, Sep 3 (IANS/EFE) The head of US Centers for Disease Control and Prevention (CDC) Tuesday warned of the risk that the Ebola outbreak could get out of control without a greater worldwide response.
 
 
US doctor tests positive for Ebola in Liberia
Washington, Sep 3 (IANS) An American missionary doctor working in Liberia has tested positive for the Ebola virus, his organisation SIM USA announced Tuesday.
 
 
IS video shows beheading of second US journalist
Washington, Sep 2 (IANS) Days after the beheading of American photojournalist James Foley, Sunni militant group Islamic State (IS) has posted a video showing the beheading of another kidnapped American journalist Steven Sotloff, CNN reported.
 
 
IS beheads second US journalist
Washington, Sep 2 (IANS) The Islamic State militant organisation has posted a video titled "A second message to America", showing the beheading of American journalist Steven Sotloff, CNN reported.
 
 
 

Latest from the Network

US warplanes drop leaflets on Iraqi city
Baghdad, Sep 3 (IANS/EFE) US warplanes Tuesday dropped thousands of leaflets on the northern Iraqi city of Mosul, urging residents to keep clear of places occupied by the Islamic State (IS) extremist group that overran...
Read more on Politics Balla
 
US CDC calls for global response against Ebola
Washington, Sep 3 (IANS/EFE) The head of US Centers for Disease Control and Prevention (CDC) Tuesday warned of the risk that the Ebola outbreak could get out of control without a greater worldwide response. "This is...
Read more on Business Balla
 
Don't have a perfect body: Charlize Theron
Los Angeles, Sep 3 (IANS) Actress Charlize Theron says she doesn't have an ideal figure, but is happy with the way her body looks. The actress features on the cover of Modern Luxury's September 2014 issue and looks...
Read more on Celebrity Balla
 
Kate Hudson is 'basically married'
Kate Hudson says she and Matthew Bellamy are ''basically married.'' The 35-year-old actress, who has son Bingham, three, with the Muse frontman, 36, admits they're in no rush to plan to a wedding and she rarely wears...
Read more on Celebrity Balla
 
Cee Lo Green's reality show is axed
Cee Lo Green's reality TV series has been axed. TBS announced on Tuesday (09.02.14) that the 'Forget You' hitmaker's show, 'The Good Life,' which focused on his attempts to juggle his careers as a producer, recording...
Read more on Celebrity Balla
 
Chris Martin spends weekend with Gwyneth Paltrow
Chris Martin and Gwyneth Paltrow spent the weekend together in the Hamptons. The former couple, who announced they were ''consciously uncoupling'' in late March after 10 years of marriage, reunited at their home in the...
Read more on Celebrity Balla
 
Mali mine blast kills four UN peacekeepers
Bamako, Sep 3 (IANS) Four United Nations peacekeepers were killed and 15 others injured after their vehicle hit a landmine in Mali Tuesday, security sources said. The UN vehicle was hit by a landmine when the...
Read more on Politics Balla
 
Kate, Cara new faces of Burberry's latest fragrance
London, Sep 3 (IANS) Supermodels Kate Moss and Cara Delevingne have been roped in as the new faces of Burberry's latest fragrance. The models are pictured in the campaign for the label's latest scent My Burberry, shot...
Read more on Celebrity Balla
 
Former Israeli PM on trial again for corruption
Jerusalem, Sep 3 (IANS) Israel's former Prime Minister Ehud Olmert appeared before a Jerusalem court Tuesday after the state prosecution reopened a corruption case against him. Olmert was acquitted in what came to be...
Read more on Politics Balla
 
11 killed in Argentina van accident
Buenos Aires, Sep 3 (IANS/EFE) At least 11 people were killed Tuesday when a van carrying teachers collided with a truck in Argentina, police said. The accident occurred about 7.45 a.m. near El Simbol, 1,000 km north...
Read more on Politics Balla